MolNFT v2 · #122108 · protein
Structure of complement C5 in complex with eculizumab
5I5K: “Structure of complement C5 in complex with eculizumab”. X-ray diffraction at 4.2, 2 ligands (NAG, BMA). MolNFT v2 #122108 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5I5K
- Type
- protein
- Length
- 4,134 residues
- Chains
- 6
- Method
- x-ray diffraction
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 4.2
- Source
- Homo sapiens
- UniProt
- P01031
- Ligands
- NAG, BMA
Structure
x-ray diffraction · resolution 4.2 · 4 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| B | — | protein | 1634 | — | P01031 |
| H, X | — | protein | 221 | — | — |
| L, Y | — | protein | 213 | — | — |
| A | — | protein | 1632 | — | P01031 |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains B, A
- BMA · beta-D-mannopyranose · sugar · 2 copies
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P01031
- Elsewhere: RCSB PDB 5I5K · PDBe 5I5K · UniProt P01031
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.